Suzhou Siran Biotechnology

Privately held: no public share price · China

Assets

(2 total)
2Total Assets
0Approved
0Phase 3 / Filed
2Phase 1–2 / Early
2Diseases
Quick filter:
Showing 2 of 2 assets
Target & Modality
Phase 1
ALK7 (Activin receptor-like kinase 7)RNA / oligonucleotide
Obesity
Phase 1
Hepatitis B virus RNA (dual-target siRNA)RNA / oligonucleotide
Chronic Hepatitis B

Upcoming events

No upcoming trial completions or earnings dates on record for this company's assets.

Financial reports

No financial reports recorded.